EO Care Launches Free AI-Driven Cannabinoid Recommendation Platform for Older Adults and Cancer Patients
EO Care has launched a free digital platform designed to provide personalised cannabinoid recommendations to older adults and cancer patients. The platform aims to fill the gap in clinical guidance for millions of Americans who regularly use cannabis for symptom management.
EO Care's platform is built on a Bayesian AI engine that learns from thousands of patient interactions and peer-reviewed research. It considers patient inputs, clinical outcomes, and clinical exclusion rules to generate tailored recommendations.
The platform offers ongoing messaging and phone support from EO's clinician-trained team at no cost to patients. This comprehensive approach represents a bet that personalised, algorithm-driven guidance can improve outcomes for a population already using cannabinoids, often without medical supervision.
Developed and tested in collaboration with patients and clinicians at leading hospitals and NCI-designated cancer centres, the platform is now available at eo.care. EO's board and investor roster include prominent healthcare figures, such as former Surgeon General Regina Benjamin, reflecting the platform's commitment to clinical credibility.
With 21% of Americans over 50 and up to 40% of cancer patients using cannabis regularly for symptom management, the need for clinical oversight is clear. EO Care's free cannabinoid care platform addresses this need, offering personalised recommendations and ongoing support to improve patient outcomes.
